Macnica (hereinafter referred to as Macnica, head office location: Yokohama City, Kanagawa Prefecture, President: Kazumasa Hara), a total service/solution provider in semiconductors, networks, cybersecurity, and AI/IoT, conducts lifestyle habits through 24-hour vital monitoring. We are pleased to announce that we have begun our efforts to combat the disease and have entered into a capital and business alliance and exclusive sales agreement with Arblet Co., Ltd. (Headquarters: Shibuya-ku, Tokyo, Representative Board Director: Akira Shimizu).
In an age where the super-aging society is in full swing, society as a whole is required to create systems that allow more people to live long, high-quality lives. Therefore, Macnica uses advanced technology to convert "vital fluctuations in daily life" into data, which medical care has not been able to intervene with up until now, and connect them to data, thereby improving the quality of life (QOL) of each individual and improving medical resources. We would like to realize innovations in the efficient use of Recognizing these challenges, Macnica will leverage its strengths and work with Arblet to jointly develop solutions for the prevention, treatment, and prognosis of lifestyle-related diseases.
Arblet's Solution
A variety of vital data (blood pressure *1, pulse, wrist surface temperature, breathing rate, stress, sleep, etc.) and behavioral information of consumers can be collected at the same time by using a wrist-worn wearable device (Arblet device) and an analysis algorithm on the cloud. time monitoring. Among them, non-avascular blood pressure measurement enables continuous observation of sleep blood pressure and beat-to-beat blood pressure. By combining these data with various medical research results and capturing physical or mental stress and signs of illness, we can provide not only consumers with health concerns but also healthy consumers with emergency alerts and future illnesses. We aim to provide a service that performs risk prediction.
The Arblet device is equipped with an advanced semiconductor sensor, and has a system configuration that transmits sensor data to the cloud via edge terminals such as smartphones, and processes and accumulates data using analysis algorithms on the cloud. By transferring all sensor data to the cloud and analyzing it on the cloud rather than on the edge terminal, it is possible to calculate by synchronizing vital data and behavioral information. In addition, we have adopted an architecture that makes it possible to retroactively acquire new vital data through the additional development of algorithms on the cloud.
*1) We aim to develop it so that it can be used as a medical device. (Patented)
Takuya Kishi, Chairman of the Next Generation Hypertension Committee of the Japanese Society of Hypertension and Professor of Cardiovascular Medicine, Graduate School of Medicine, International University of Health and Welfare, said:
“Hypertension is the most common lifestyle disease, with an estimated 43 million people in Japan. However, the method of blood pressure measurement is hospital or home blood pressure measurement once or twice a day, and it is not enough to understand the state of hypertension and to judge the effect of treatment, and even people who do not know their own blood pressure. It is very problematic that 33% of hypertensive patients do not have any blood pressure.In order to overcome this current situation, it is necessary to measure blood pressure with a non-avascularization type wearable device and link blood pressure data with a life log to understand the state of hypertension. As a clinician, I have great expectations for Arblet's vision, which promises such a future."
Macnica 's healthcare business
In response to social issues such as reducing social security costs against the backdrop of an ultra-aging society, extending healthy life expectancy, and building a society where people remain active throughout their lives, Macnica is working on healthcare businesses that utilize advanced technology and data. In particular, we are focusing on preventing mental health and chronic diseases (lifestyle-related diseases), including depression, which is feared to spread due to the COVID-19 pandemic, and will support people to live rich and fulfilling lives both physically and mentally.
In order to realize these goals, Macnica is combining its advanced technology sourcing capabilities accumulated over nearly 50 years of trading company business, semiconductor-level technology that serves as the core of technological innovation, IT technology capabilities centered on data management and security, and the group's approximately 80 data scientists and 25,000 data By combining the capability of AI with a community of scientists, we are collecting vital and mental data of consumers and developing healthcare solutions based on "data x AI x expertise".
*Company names and product names mentioned in this text are trademarks or registered trademarks of Macnica and each company.
*The information published in the news release is current as of the date of announcement. Please note that the information may be subject to change without prior notice.
About Arblet Inc.
Arblet is a medical, electronic engineering, and biomedical engineering department at McMaster University (Canada), the birthplace of "Evidence-Based Medicine, EBM". Founded in 2016 after studying data science. In addition to measuring behavioral and biological information in daily life, we are developing a platform that can monitor not only fixed-point absolute values but also individual changes over time.
Please see the website (https://www.arblet.com) for details.
About Macnica
Since its establishment in 1972, Macnica has provided cutting-edge semiconductors, electronic devices, networks, and cybersecurity products with added technological value. In recent years, we have been developing new businesses in fields such as AI/IoT, autonomous driving, and robots, based on our traditional strengths of global cutting-edge technology sourcing and technology planning capabilities. Going forward, under the slogan "Co.Tomorrowing," we will connect cutting-edge technology and Macnica 's intelligence to provide unique services and solutions, creating social value and contributing to the development of future society. . the Company company is headquartered in Yokohama and operates a global business with 84 locations in 24 countries around the world.
Please see the website (https://www.macnica.co.jp) for details.
Inquiries from the press regarding this matter
株式会社マクニカ https://www.macnica.co.jp
経営企画部 広報企画課 宮原 e-Mail：macpr@macnica.co.jp
〒222-8561 横浜市港北区新横浜1-6-3 マクニカ第1ビル